Terns Pharmaceuticals (TERN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Terns's Stock Soars as Analysts Cheer Leukemia Data - and Predict More Gains
MarketWatch13:19 ET
Express News | HC Wainwright & Co. Reiterates Neutral on Terns Pharma, Maintains $7.5 Price Target
BenzingaDec 4 06:57 ET
Express News | Terns Pharmaceuticals Inc : Jefferies Raises Target Price to $34 From $30
ReutersDec 4 05:51 ET
Terns Pharmaceuticals Is Maintained at Outperform by Oppenheimer
Dow JonesDec 4 04:48 ET · Ratings
Terns Pharmaceuticals Price Target Raised to $20.00/Share From $17.00 by Oppenheimer
Dow JonesDec 4 04:48 ET · Ratings
Express News | 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
BenzingaDec 3 12:11 ET

Comments

Trytosaveabit

Dec 3 06:10

Update

$Terns Pharmaceuticals (TERN.US)$ Terns Pharmaceuticals Announces Positive Early Data From Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia
GlobeNewswire· 7 mins ago
Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels
Encouraging safety profile with no dose limiting toxicities, adverse event-related treatment discontinuations, or dose reductions across three dose escalation cohorts
High leve...

frogoracletrading

Oct 30 16:10

$TERN Support / Resistance Levels

Brought it back down into the POC. If 6.47 holds could see it start curling but if shorts get control could see a push down towards 5.00
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$

5

frogoracletrading

Oct 13 14:49

$TERN Support / Resistance Levels

Back into the 240 day POC. Watch for the 7.33 level to form as a new base.
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$

4

1

Jaguar8

Sep 9 15:02

NEWS: $125M public offering

$Terns Pharmaceuticals (TERN.US)$
Terns Announces Proposed Public Offering
Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage biopharmaceutical company, has announced a proposed public offering of $125 million in common stock and pre-funded warrants. The company plans to grant underwriters a 30-day option to purchase up to an additional $18.75 million of shares. Jefferies, TD Cowen, and UBS Investment Bank are acting as bookrunners for the offering.
Terns intends to...

1

Jaguar8

Sep 9 06:21

NEWS

$Terns Pharmaceuticals (TERN.US)$
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
Terns Pharmaceuticals (Nasdaq: TERN)announced positive Phase 1 clinical trial results for TERN-601, its once-daily oral GLP-1R agonist for obesity treatment. The trial showed:
- Statistically significant mean weight loss up to 5.5% over 28 days (4.9% placebo-adjusted)
- Well-tolerated with no treatment-related dose ...

1

TERN Terns Pharmaceuticals

Trade Overview

Capital Trend

News

Comments